Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;120:417-426
Published online before print July 20, 2009, doi: 10.1161/CIRCULATIONAHA.109.868158
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
120/5/417    most recent
CIRCULATIONAHA.109.868158v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Lewis, M. J.
Right arrow Articles by Haskard, D. O.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lewis, M. J.
Right arrow Articles by Haskard, D. O.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Substance via MeSH
Related Collections
Right arrow Apoptosis
Right arrow Pathophysiology
Right arrow Genetically altered mice
Right arrowRelated Article

(Circulation. 2009;120:417-426.)
© 2009 American Heart Association, Inc.


Molecular Cardiology

Immunoglobulin M Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice

Myles J. Lewis, MSc, MRCP; Talat H. Malik, PhD; Michael R. Ehrenstein, PhD, FRCP; Joseph J. Boyle, PhD, FRCPath; Marina Botto, MD; Dorian O. Haskard, DM, FRCP

From the Rheumatology Section, Division of Medicine (M.J.L., T.H.M., M.B.), Division of Investigative Sciences (J.J.B.), Vascular Sciences Section, National Heart and Lung Institute (J.J.B., D.O.H.), Imperial College, and Department of Medicine, University College London (M.R.E.), London, UK.

Correspondence to Dorian Haskard, BHF Cardiovascular Medicine Unit, National Heart and Lung Institute, Imperial College, Hammersmith Hospital, Du Cane Rd, London, W12 0NN, UK. E-mail d.haskard{at}imperial.ac.uk

Received August 25, 2008; accepted June 2, 2009.

Background— Immunoglobulin M (IgM) natural antibodies bind oxidatively-modified low-density lipoprotein (LDL) and apoptotic cells and have been implicated as being important for protection against atherosclerosis. We have directly investigated the requirement for IgM by studying the effects of IgM deficiency in LDL receptor–deficient (Ldlr–/–) mice.

Methods and Results— Mice deficient in serum IgM (sIgM) or complement C1q were crossed with Ldlr–/– mice and studied on both low-fat and high-fat semisynthetic diets. On both diets, en face and aortic root atherosclerotic lesions in sIgM.Ldlr–/– mice were substantially larger and more complex, with accelerated cholesterol crystal formation and increased smooth muscle cell content in aortic root lesions. Combined C1q and IgM deficiency had the same effect as IgM deficiency alone. Increased apoptosis was observed in aortic root lesions of both sIgM.Ldlr–/– and C1qa.Ldlr–/– mice. Because lesions were significantly larger in IgM-deficient mice than in the absence of C1q, IgM protective mechanisms appear to be partially independent of classical pathway activation and apoptotic cell clearance. Levels of IgG antibodies against copper-oxidized LDL were lower in sIgM.Ldlr–/– mice fed a high-fat diet, suggesting compensatory consumption of IgG in the absence of IgM.

Conclusions— This study provides direct evidence that IgM antibodies play a central role in protection against atherosclerosis. The mechanism appears to be at least partly independent of classical pathway complement activation by C1q.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2009 120: 355-356. [Extract] [Full Text]



This article has been cited by other articles:


Home page
The Journal of RheumatologyHome page
D. J. GRAINGER
When Worlds Collide: Autoimmunity and Atherosclerosis
J Rheumatol, November 1, 2009; 36(11): 2378 - 2379.
[Full Text] [PDF]


Home page
The Journal of RheumatologyHome page
A. DORIA
Atherosclerosis and Lupus: What We Know and What We Should Know
J Rheumatol, November 1, 2009; 36(11): 2380 - 2382.
[Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Durand, K. Hartvigsen, L. Fogelstrand, S. Kim, S. Iritani, B. Vanhaesebroeck, J. L. Witztum, K. D. Puri, and M. R. Gold
Phosphoinositide 3-Kinase p110{delta} Regulates Natural Antibody Production, Marginal Zone and B-1 B Cell Function, and Autoantibody Responses
J. Immunol., November 1, 2009; 183(9): 5673 - 5684.
[Abstract] [Full Text] [PDF]